Middle East and Africa miRNA Sequencing and Assay Market to Grow at a CAGR of 12.4% to reach US$ 22.00 Mn Million from 2019 to 2027

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Middle East and Africa miRNA Sequencing and Assay Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Middle East and Africa miRNA Sequencing and Assay Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Expansion of technologically advanced sequence analysis platforms

5.2 Market Opportunities

5.2.1 Role of miRNA in immune response regulation

5.3 Future Trends

5.3.1 Rising adoption of miRNA sequencing in healthcare industry

5.4 Impact of Drivers and Restraints

6. Middle East and Africa miRNA Sequencing and Assay Market Regional Analysis

6.1 Middle East and Africa miRNA Sequencing and Assay Market Overview

6.2 Middle East and Africa miRNA Sequencing and Assay Market Revenue 2017-2027 (US$ Million)

6.3 Middle East and Africa miRNA Sequencing and Assay Market Forecast Analysis

7. Middle East and Africa miRNA Sequencing and Assay Market Analysis – by Product

7.1 Library Preparation

7.1.1 Overview
7.1.2 Library Preparation: Middle East and Africa miRNA Sequencing and Assay Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Consumables

7.2.1 Overview
7.2.2 Consumables: Middle East and Africa miRNA Sequencing and Assay Market – Revenue and Forecast to 2031 (US$ Million)

8. Middle East and Africa miRNA Sequencing and Assay Market Analysis – by Technology

8.1 Sequencing Synthesis

8.1.1 Overview
8.1.2 Sequencing Synthesis: Middle East and Africa miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

8.2 Nanopore

8.2.1 Overview
8.2.2 Nanopore: Middle East and Africa miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

8.3 Ion Semiconductor Sequencing

8.3.1 Overview
8.3.2 Ion Semiconductor Sequencing: Middle East and Africa miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

9. Middle East and Africa miRNA Sequencing and Assay Market Analysis – by End User

9.1 Research Institute

9.1.1 Overview
9.1.2 Ion Semiconductor Sequencing: Middle East and Africa miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

9.2 Academia

9.2.1 Overview
9.2.2 Ion Semiconductor Sequencing: Middle East and Africa miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

9.3 CRO

9.3.1 Overview
9.3.2 Ion Semiconductor Sequencing: Middle East and Africa miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

10. Middle East and Africa miRNA Sequencing and Assay Market – Middle East and Africa Analysis

10.1 Middle East and Africa

10.1.1 Middle East and Africa miRNA Sequencing and Assay Market Breakdown, by Key Country, 2020 and 2027 (%)
10.1.1.1 Middle East and Africa miRNA Sequencing and Assay Market – Revenue and Forecast Analysis – by Country
10.1.1.1 South Africa: Middle East and Africa miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.1.1 South Africa: Middle East and Africa miRNA Sequencing and Assay Market Breakdown, by Product
10.1.1.1.2 South Africa: Middle East and Africa miRNA Sequencing and Assay Market Breakdown, by Technology
10.1.1.1.3 South Africa: Middle East and Africa miRNA Sequencing and Assay Market Breakdown, by End User

10.1.1.2 Saudi Arabia: Middle East and Africa miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.2.1 Saudi Arabia: Middle East and Africa miRNA Sequencing and Assay Market Breakdown, by Product
10.1.1.2.2 Saudi Arabia: Middle East and Africa miRNA Sequencing and Assay Market Breakdown, by Technology
10.1.1.2.3 Saudi Arabia: Middle East and Africa miRNA Sequencing and Assay Market Breakdown, by End User

10.1.1.3 UAE: Middle East and Africa miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.3.1 UAE: Middle East and Africa miRNA Sequencing and Assay Market Breakdown, by Product
10.1.1.3.2 UAE: Middle East and Africa miRNA Sequencing and Assay Market Breakdown, by Technology
10.1.1.3.3 UAE: Middle East and Africa miRNA Sequencing and Assay Market Breakdown, by End User

10.1.1.4 Rest of Middle East and Africa: Middle East and Africa miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.4.1 Rest of Middle East and Africa: Middle East and Africa miRNA Sequencing and Assay Market Breakdown, by Product
10.1.1.4.2 Rest of Middle East and Africa: Middle East and Africa miRNA Sequencing and Assay Market Breakdown, by Technology
10.1.1.4.3 Rest of Middle East and Africa: Middle East and Africa miRNA Sequencing and Assay Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Middle East and Africa miRNA Sequencing and Assay Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Illumina, Inc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 THERMO FISHER SCIENTIFIC INC.

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 QIAGEN

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Perkin Elmer, Inc.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Takara Bio Inc.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 New England Biolabs

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Norgen Biotek Corp

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 TriLink BioTechnologies Inc.

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Lexogen GmbH

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Oxford Nanopore Technologies

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights